General practitioners' perceptions of the tolerability of antidepressant drugs: A comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants

British Medical Journal

Volumn 314, Issue 7081, 1997, Pages 646-651

  Martin, Richard M ^a   Hilton, Scan R ^b   Kerry, Sally M ^a   Richards, Nicky M ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Send ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GENERAL PRACTITIONER; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; PERCEPTION; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT FAILURE; UNITED KINGDOM;

EID: 0031046527     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.314.7081.646     Document Type: Article

References (37)

1. Prescription Pricing Authority. Depression and antidepressants. PACT report, Newcastle upon Tyne: PPA, 1995.
2. Edwards J. Selective serotonin reuptake inhibitors: a modest though welcome advance in the treatment of depression. D. MJ 1992:304:1644-6.
3. Harrison G. New or old antidepressants? New is better. BMJ 1994:309:1280-1.
4. Owens D. New or old antidepressants? Benefits of new drugs are exaggerated BMJ 1994;309:1281-2.
5. British Association for Psychopharmacology. Guidelines for treating depressive illness with antidepressants. J Psychopharmacol 1993;7:19-23
6. Effective Health Care, The treatment of depression in primary care. Leeds: University of Leeds, 1993.
7. I. ader M. Fluoxetine efficacy vs comparative drugs: an overview, Br J Psychiatry 1988:153(suppl3):51-8.
8. Song F, Freemanüe N, Sheldon TA, House A, Watson P, Long A, et al. Selective serotonin reuptake inhibitors in depression: a meta-analysis of efficacy and acceptability. BM J 1993;306:683-7.
9. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inliibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995;310:1433-8.
10. Effective and acceptable treatment for depression. BMJ 1993;306:11247. (Correspondence. )
11. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. J Chronic Dis 1967;20:637-48.
12. Sireling LI, Paykel ES, Freeling P, Rao BM, Patel SP. Depression in general practice: clinical features and comparison with out-patients. Br J Psychiatry 1985:147:119-26.
13. Sireling LI, Paykel ES, Freeling P, Rao BM, Patel SP. Depression in general practice: case thresholds and diagnosis. Br J Psychiatry 1985;147:113-8.
14. Johnson DAW Treatment of depression in general practice. BMJ 1973;2:18-20.
15. Thompson C, Thompson CM. The prescribing of antidepressants in general practice: 1: a critical review. Hum Psychopharmacol 1989:4:91-102.
16. Burgess I. The incidence and treatment of NSAID induced GI symptoms. Horizons 1990;4:433-6.
17. Martin R, Hilton S, Kerry S. Review of prescribed treatment for children with astluna-more recent data suggest guidelines are being adhered la BMJ 1995:311:1645.
18. Joint Formulary Committee. British national formulary. No 29. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1995:165-8.
19. Central Statistical Office. Regional trends. No 30. London: HMSO, 1995.
20. General Medical Services Committee. Basic statistics. England and Wales national and regional tables. Leeds: Department of I lealth NUS Executive Headquarters, 1993.
21. Olfson M, Klerman GL. Trends in the prescription of antidepressants by office-based psychiatrists. Am J Psychiatry 1993:150:571-7.
22. Pa) kel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1992;305:1198-202.
23. Maddox JC, Levi M, Thompson C. The compliance with antidepressants in general practice. /Psychopharmaml 1994;8:48-53.
24. MacDonald TM, Mc. Mahon AD, Reid 1C, Fenton GW, McDevitt DG. Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland. BMJ 1996;313:860-1.
25. Simon GE, VonKorff M, Heiligenstein J H, Revicki DA, Grothaus L, Katon W, et al. Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs triq'clic antidepressants. JAMA 1996;275:1897-902.
26. Montgomery SA, Henry J, McDonald G, Dinan T, Lader M. Hindmarcli I, et al. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates, // Clin Psychopharmacol 1994;9:47-53.
27. Anderson IM. Tomenson BM. The efficacy of selective serotonin reuptake inliihitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 994:8:238-49.
28. Donoghue JM. Tylee A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 1996;168:161-8.
29. Ramchandani P, Webb V. Acceptability of side effects as reason for stopping may bias results. BMJ 1995;311:751.
30. Andrade SE, Walker AM, Göttlich LK, I lollenberg NK, Testa MA, Saperia GM, et al. Discontinuation of antihyperlipidemic drugs-do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 1995;332:1125-31.
31. Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost effectiveness of pharmacological treatment. Br J Psychiatry 1994;164:665-73.
32. O'Brien JT. Cost-effectiveness of antidepressants. Br J Psychiatry 1994;165:411-2.
33. Edwards JG, Inman WH, Wilton L, Pearce GU Prescription-event monitoring of 10 401 patients treated with fluvoxamine. Br J Psychiatry 1994:164:387-95.
34. Brown WA, Harrison W. Arc patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry 1995;56:30-4.
35. Isacsson G, Redfors I, Wasserrnan D, Bergman U. Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas in Sweden. BMJ 1994:309:1516-9.
36. Donoghue J, Tylce A, Wildgust H. Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993-5. BMJ 1996:313:861-2.
37. Cohn CK, Shrivastava R, Mendels J, Cohn JB, Fabre LF, Claghorn JL, et al. Double-blind, multicenter comparison of scrtraline and amitriptyline in elderly depressed patients. J Clin Pfschiatrt 1990;51:28-33.